Hypertension and Chronic Kidney Disease Including Dialysis
Authors:
- Omar Al DhaybiODOmar Al Dhaybi
- George L. BakrisGBGeorge L. Bakris
- 5 October 2023
- book chapter
- Published by Elsevier
- p. 393-404
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic NephropathyJournal of the American Society of Nephrology, 2009
- Renal and Retinal Effects of Enalapril and Losartan in Type 1 DiabetesNew England Journal of Medicine, 2009
- Blood Pressure Components and the Risk for End-Stage Renal Disease and Death in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP)Hypertension, 2009
- Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred CohortAmerican Journal of Kidney Diseases, 2008
- Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of LifeJAMA, 2007
- Reverse Epidemiology of Hypertension and Cardiovascular Death in the Hemodialysis PopulationHypertension, 2005
- Causes and Consequences of Increased Sympathetic Activity in Renal DiseaseHypertension, 2004
- Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathyJACC, 2003
- Plasma endothelin levels in hypertension and chronic renal failure.Hypertension, 1990